Polyclonal Anti-AHNAK2 Antibody
Highest antigen sequence identity to the following orthologs:
Mouse ENSMUSG00000072812 (67%)
Rat ENSRNOG00000028545 (63%)
Dilution: 1:200 - 1:500
Retrieval method: HIER pH6
Fixation/Permeabilization: PFA/Triton X-100
Working concentration: 0.25-2 µg/ml
Orthogonal validation of protein expression using IHC by comparison to RNA-seq data of corresponding target in high and low expression tissues.
This antibody has been used for staining of 44 normal human tissue samples as well as human cancer samples covering the 20 most common cancer types and up to 12 patients for each cancer type. The results are part of an ongoing effort to map the human proteome using antibodies.
Prognostic Impact of AHNAK2 Expression in Patients Treated with Radical Cystectomy
Cancers (Basel) , 2021 Apr 9; 13(8):1748. Epub 2021 Apr 9
AHNAK2 Is Associated with Poor Prognosis and Cell Migration in Lung Adenocarcinoma
Biomed Res Int , 2020 Aug 20; 2020:8571932. Epub 2020 Aug 20
AHNAK2 is a potential prognostic biomarker in patients with PDAC
Oncotarget , 2017 Mar 7; 8(19):31775-31784. Epub 2017 Mar 7
Contribution of antibody-based protein profiling to the human Chromosome-centric Proteome Project (C-HPP).
J Proteome Res , 2013 Jun 7; 12(6):2439-48. Epub 2012 Dec 31
Join the Explorer Program
Are you using our products in an application or species we have not yet tested? Why not participate in the Explorer Program, and we will show your contribution here. If you would like to share your results with us, the Explorer Program offers a 25µl vial free of charge with your next order.